RESEARCH
Our
research interests
lie
at the interface of neurobiology and psychiatry. Experiments
conducted in our laboratory apply basic neuropharmacological approaches
to the study of central dopaminergic systems, with the ultimate goal of
determining the neurobiological correlates of mental disorders and the
modes of action of psychotherapeutic drugs. One aspect of this research
involves the study of the basic physiological properties of
neurochemically identified neurons. Using in vivo and in vitro
intracellular recording techniques, neurons are injected with highly
fluorescent dyes to outline their morphology, and specific blockers are
used to study the ionic mechanisms involved in generating action
potentials and regulating the activity states of these cells. By first
characterizing the biophysical properties of identified neurons, the
processes contributing to their responses to pharmacological agents,
such as those that play a role in the exacerbation or therapeutic
treatment of psychiatric disorders, may be interpreted at a more
mechanistic level.
Another aspect of the research in our laboratory involves the use of
animal models of psychiatric disorders. Ongoing studies into the
neurobiology of schizophrenia involve study of the interaction of the
prefrontal cortex and antipsychotic drugs with subcortical dopamine
systems. Additional studies are aimed at identifying the role of
dopamine neurons in the recovery of behavioral function after partial
dopamine-depleting brain lesions, which model the pathology seen in
Parkinson's disease in humans. The techniques employed in these
analyses include:
- producing
neurochemically specific lesions of neurons
- anatomical
studies of identified neurons and neurotransmitter pathways
- recordings
of identified neurons using intracellular and extracellular
electrophysiological techniques
- use
of microiontophoresis to assess the responses of individual neurons to
directly applied drugs
Through this approach, the basic neurobiological processes that
contribute to psychiatric disorders may be elucidated, and insight may
be gained into more effective therapeutic strategies for treating these
diseases in humans.